Equinoxe
Device Orthopaedic
General payments
$11,979,650
Research payments
$3,132,786
Through program year 2021, $11,979,650 in general payments and $3,132,786 in research payments were reported against Equinoxe (Orthopaedic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $3,599,283 | 1,335 |
| 2021 | Research | $1,178,846 | 71 |
| 2020 | General | $2,569,174 | 634 |
| 2020 | Research | $1,056,661 | 58 |
| 2019 | General | $5,811,193 | 1,746 |
| 2019 | Research | $897,280 | 42 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
3,715 general · 171 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.